PT Medco Energi Internasional (MEDC) Q4 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2023 earnings summary
31 Oct, 2026Executive summary
Met 2023 operational guidance; oil and gas production was 160 mboepd, power sales reached 4,155 GWh, and oil and gas cash cost was $8.3/boe.
Focused on long-term value through gas portfolio growth, clean power and renewables expansion, reserve additions, and copper and gold interests.
Financial highlights
FY23 revenue was $2.249bn, gross profit $1.034bn, EBITDA $1.255bn, and net income $331m.
EBITDA and net income were below 2022, reflecting lower commodity prices; AMMN net income was affected by severe rainfall and export permit delays.
Realized prices were $78/bbl for oil and $7.0/MMBTU for gas.
Outlook and guidance
2024 guidance: oil and gas production 145 mboepd, power sales 4,100 GWh, capex $430m, cash cost below $10/boe, and Restricted Group net debt/EBITDA below 2.5x at $65/bbl mid-cycle pricing.
2024 capex is $350m for oil and gas, focused on Natuna, Corridor and Oman Block 60 drilling, and $80m for power, focused on Ijen Geothermal and Bali PV.
Planned priorities include completing Natuna projects, advancing Corridor, Senoro and Tanzania developments, and progressing Bulan PV and Ijen Geothermal.
Guidance includes new reserves from Natuna, Corridor, Senoro, Tanzania and Oman Block 60; selective portfolio management and continued dividends and debt repayments.
Latest events from PT Medco Energi Internasional
- Net income surged 640% on strong production, higher prices, and improved financial metrics.MEDC
Q2 2026 - Q1 2026 net income surged to $67.4M on 19% revenue growth and strong oil & gas output.MEDC
Q1 2026 - Met guidance with stable EBITDA, portfolio growth, and record shareholder returns.MEDC
Q4 2025 - Stable EBITDA and higher dividends offset lower net income amid major asset acquisitions.MEDC
Q3 2025 - EBITDA dropped 4% to $623M in 1H 2025; major Corridor PSC stake acquired.MEDC
Q2 2025 - Diversified energy operations, robust growth, and ESG leadership drive superior shareholder returns.MEDC
CMD 2024 Presentation - Q1 EBITDA rose to $332mn, with strong operations, liquidity, and key project milestones achieved.MEDC
Q1 2025 - Net income and revenue rose in 9M 2024, supported by asset optimization and strong cash flow.MEDC
Q3 2024 - Net income surged 68.9% to US$201mn on higher revenue, asset sales, and Oman gain.MEDC
Q2 2024